MSM Stock Overview
Engages in the distribution of implants and other medical materials used in the treatment of musculoskeletal system diseases and regenerative medicines in Poland. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Massmedica S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | zł6.10 |
| 52 Week High | zł9.00 |
| 52 Week Low | zł2.20 |
| Beta | 0.056 |
| 11 Month Change | -10.29% |
| 3 Month Change | -1.61% |
| 1 Year Change | n/a |
| 33 Year Change | 8.93% |
| 5 Year Change | 75.29% |
| Change since IPO | -21.79% |
Recent News & Updates
Massmedica S.A.'s (WSE:MSM) 26% Share Price Surge Not Quite Adding Up
Oct 12
Massmedica S.A.'s (WSE:MSM) Shares Climb 31% But Its Business Is Yet to Catch Up
Aug 07Recent updates
Massmedica S.A.'s (WSE:MSM) 26% Share Price Surge Not Quite Adding Up
Oct 12Massmedica S.A.'s (WSE:MSM) Shares Climb 31% But Its Business Is Yet to Catch Up
Aug 07There's Reason For Concern Over Massmedica S.A.'s (WSE:MSM) Massive 44% Price Jump
Jun 20Optimistic Investors Push Massmedica S.A. (WSE:MSM) Shares Up 41% But Growth Is Lacking
Mar 07Calculating The Intrinsic Value Of Massmedica S.A. (WSE:MSM)
Jan 05I Ran A Stock Scan For Earnings Growth And Massmedica (WSE:MSM) Passed With Ease
Sep 14Massmedica S.A.'s (WSE:MSM) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?
Dec 15
Shareholder Returns
| MSM | PL Healthcare | PL Market | |
|---|---|---|---|
| 7D | -1.6% | -4.1% | -3.1% |
| 1Y | n/a | 11.2% | -1.7% |
Return vs Industry: Insufficient data to determine how MSM performed against the Polish Healthcare industry.
Return vs Market: Insufficient data to determine how MSM performed against the Polish Market.
Price Volatility
| MSM volatility | |
|---|---|
| MSM Average Weekly Movement | 10.4% |
| Healthcare Industry Average Movement | 4.1% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in PL Market | 8.6% |
| 10% least volatile stocks in PL Market | 3.0% |
Stable Share Price: MSM's share price has been volatile over the past 3 months compared to the Polish market.
Volatility Over Time: MSM's weekly volatility has decreased from 18% to 10% over the past year, but is still higher than 75% of Polish stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2011 | 19 | Marek Mlodzianowski | www.massmedica.com |
Massmedica S.A. engages in the distribution of implants and other medical materials used in the treatment of musculoskeletal system diseases and regenerative medicines in Poland. It offers products in the field of reconstructive, regenerative, anti-aging, and aesthetic medicine. The company’s products include dietary supplements, skin care cosmetics, sun protection creams, tools for home treatments, and intra-articular injections for regeneration of the knee joints.
Massmedica S.A. Fundamentals Summary
| MSM fundamental statistics | |
|---|---|
| Market cap | zł14.97m |
| Earnings (TTM) | zł719.11k |
| Revenue (TTM) | zł31.90m |
20.5x
P/E Ratio0.5x
P/S RatioIs MSM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MSM income statement (TTM) | |
|---|---|
| Revenue | zł31.90m |
| Cost of Revenue | zł20.19m |
| Gross Profit | zł11.71m |
| Other Expenses | zł10.99m |
| Earnings | zł719.11k |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.30 |
| Gross Margin | 36.71% |
| Net Profit Margin | 2.25% |
| Debt/Equity Ratio | 78.3% |
How did MSM perform over the long term?
See historical performance and comparison